Schedule 13G ownership disclosure

Maravai LifeSciences Holdings Inc

Common Stock · CUSIP: 56600D107

Event date: 2025-06-30

Filing-level shares
9,380,547
Percent of class
6.51%
  • The Vanguard Group

    Shares: 9,380,547 · Class: 6.51%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000955
Form type
SCHEDULE 13G/A
Filer
MARAVAI LIFESCIENCES HOLDINGS, INC.
CIK
CIK 1823239
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub